Hims & Hers introduces 6-month Wegovy new customer offer

Hims & Hers Health (HIMS) announced eligible customers can access 6 months of prescription-only Wegovy at a new, affordable price, “making proven obesity care and treatments more accessible, more affordable, and more connected for millions of Americans,” the company stated. Starting today, new customers eligible for Wegovy on the Hims & Hers platform can access their care for $549 per month for 6 months for a limited-time only, the company stated. “We are always looking for long-term, sustainable ways to increase access to care for our customers. This is another example of how we’re working together with the industry to bring people closer to the care and treatments they need,” said Andrew Dudum, CEO and co-founder of Hims & Hers.